| Ytd | -15.48% | |
| 1y | -8.52% |
| Open | 170.75 | Prev Close | 168.51 | Low | 168.04 | High | 173.94 | Mkt Cap | 1.09B |
| Vol | 42.87K | Avg Vol | 165.41K | EPS | 8.27 | P/E | 20.46 | Forward P/E | 17.57 |
| Beta | 0.66 | Short Ratio | 1.63 | Inst. Own | 92.14% | Dividend | 2.28 | Div Yield | 1.29 |
| Ex Div Date | 08-25 | Earning | 08-06 | 50-d Avg | 158.15 | 200-d Avg | 171.61 | 1yr Est | 250.50 |
CRAI's 20% three-month gain is backed by broader demand, a stronger project pipeline and higher fisc
CRAI's broader demand and raised fiscal 2026 revenue outlook bolster growth, but margin pressure, ca
Charles River Associates beat Q2 earnings and revenue estimates on broad-based growth, while raising
CRA International, Inc. (CRAI) Q2 2026 Earnings Call Transcript
CRA International (CRAI) came out with quarterly earnings of $2.16 per share, beating the Zacks Cons
CRA Intl (NASDAQ:CRAI) raises FY2026 sales outlook from $785.000 million-$805.000 million to $805.00
CRA Intl (NASDAQ:CRAI) reported quarterly earnings of $2.16 per share which beat the analyst consens
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing ec
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing ec
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing ec
Charles River Associates (NASDAQ: CRAI - Get Free Report)'s stock price gapped down prior to trading
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing ec
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing ec
Investors need to pay close attention to CRAI stock based on the movements in the options market lat
Charles River Associates' global talent network, cross-border expertise, and rising dividends and bu
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX:BCT) ("BriaCell" or the "Company&
PHILADELPHIA and VANCOUVER, British Columbia, July 07, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutic
CRAI benefits from rising demand for specialized advisory services, but AI, talent costs and fierce
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies
Rising talent costs, persistent inflation and cautious corporate spending are weighing on the consul
[url="]Charles River Associates[/url] (NASDAQ: CRAI), a worldwide leader in providing [url="]economi
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing ec
On May 29, 2026, CRA International Inc (CRAI) shares fell 6.5% today, bringing the current price to
Charles River shares remained flat after Q1 results, as an earnings miss and weak 2026 revenue outlo
CRA International, Inc. (CRAI) Q1 2026 Earnings Call Transcript
CRA Intl (NASDAQ:CRAI) affirms FY2026 sales outlook from $785.000 million-$805.000 million to $785.0
CRA Intl (NASDAQ:CRAI) reported quarterly earnings of $1.99 per share which missed the analyst conse
Barrington Research analyst Kevin Steinke maintains CRA Intl (NASDAQ:CRAI) with a Outperform and
CRA Intl (NASDAQ:CRAI) reported quarterly earnings of $2.06 per share which missed the analyst conse
Barrington Research analyst Kevin Steinke maintains CRA Intl (NASDAQ:CRAI) with a Outperform and
Barrington Research analyst Kevin Steinke maintains CRA Intl (NASDAQ:CRAI) with a Outperform and
Barrington Research analyst Kevin Steinke maintains CRA Intl (NASDAQ:CRAI) with a Outperform and
CRA Intl (NASDAQ:CRAI) raises FY2025 sales outlook from $730.000 million-$745.000 million to $740.00
Quarterly DividendOn October 30, 2025, CRA announced that it increased its quarterly cash dividend b
CRA Intl (NASDAQ:CRAI) reported quarterly earnings of $2.06 per share which beat the analyst consens
CRA Intl (NASDAQ:CRAI) raises FY2025 sales outlook from $715.000 million-$735.000 million to $730.00
CRA Intl (NASDAQ:CRAI) reported quarterly earnings of $1.88 per share which beat the analyst consens
Barrington Research analyst Kevin Steinke maintains CRA Intl (NASDAQ:CRAI) with a Outperform and
CRA Intl (NASDAQ:CRAI) affirms FY2025 sales outlook from $715.00 million-$735.00 million to $715.00
CRA Intl (NASDAQ:CRAI) reported quarterly earnings of $2.22 per share which beat the analyst consens
Chad Holmes, CRA's Chief Corporate Development Officer and former CFO, will serve as interim CFO
Barrington Research analyst Kevin Steinke maintains CRA Intl (NASDAQ:CRAI) with a Outperform and
CRA Intl (NASDAQ:CRAI) reported quarterly adjusted earnings of $2.03 per share which beat the analys